Evotec SE

Evotec is a global life science company that pioneered a unique business model focused on drug discovery alliances and development partnerships. The company operates through two main segments: 'Shared R&D', which provides high-end drug discovery services to partners, and 'Just – Evotec Biologics', which focuses on AI-driven continuous manufacturing of biologics. Evotec is renowned for its 'Data-driven R&D Autobahn to Cures,' a platform that integrates high-throughput screening, iPSC (induced pluripotent stem cell) technology, and multi-omics to accelerate drug development. Rather than developing a proprietary internal pipeline for commercialization, Evotec builds a massive 'co-owned' pipeline of over 100 assets with partners like Bristol Myers Squibb, Sanofi, and Novo Nordisk, earning milestones and royalties upon success.